SCHEMBL4073509

SCHEMBL4073509

Clc1cc(-c2cccnc2)nc(-c2ccccn2)n1.c1ccc(-c2nc(NCCc3cccc4[nH]ccc34)cc(-c3cccnc3)n2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43
GBA1 P04062 1/20 0.42
CYP3A4 P08684 5/20 0.41
CYP1A2 P05177 4/20 0.41
CYP2D6 P10635 4/20 0.41
CYP2C19 P33261 4/20 0.41
CLK4 Q9HAZ1 4/20 0.41
USP2 O75604 3/20 0.41
CYP2C9 P11712 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 2/20 0.41
ALOX15 P16050 1/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PTGDR Q13258 4/20 0.37
PIM1 P11309 3/20 0.37
PIM2 Q9P1W9 2/20 0.37
PIM3 Q86V86 1/20 0.37
CYP2A6 P11509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2241460 0.95 CDK4 (0.47) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2240050 0.86 CYP3A4 (0.46) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL3962080 0.84 CDK4 (0.58) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2240699 0.84 CYP3A4 (0.44) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL3718274 0.83 CDK4 (0.45) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2239858 0.81 HPGD (0.57) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2239769 0.81 CYP1A2 (0.49) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2237295 0.80 CYP2A6 (0.45) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2240988 0.79 CDK4 (0.49) CDK4CCND1GBA1CYP3A4CYP1A2
SCHEMBL2238638 0.78 PTGDR (0.47) CYP3A4CYP1A2CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP disclosed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO disclosed